CLEARASIL ULTRA ACNE PLUS MARKS WASH AND MASK- salicylic acid lotion 
RB Health (US) LLC

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

Clearasil ® Ultra

Acne Plus Marks Wash and Mask

Drug Facts

Active ingredient

Salicylic acid 2%

Purpose

Acne medication

Use

for the treatment of acne

Warnings

For external use only

When using this product

  • avoid contact with the eyes. If product gets into the eyes, rinse thoroughly with water
  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time
  • limit use to the face and neck

Stop use and ask a doctor if skin or eye irritation develops

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

Directions

  • As a daily wash - wet face. Dispense product into hands, lather and massage gently onto face and neck, avoiding the eye area
  • rinse thoroughly with warm water and gently pat dry.
  • because excessive drying of the skin may occur, start with one application daily, then gradually increase to two or three times daily if needed or as directed by a doctor
  • if bothersome dryness or peeling occurs, reduce the application to once a day or every other day.
  • As a mask - use up to 3 times a week for a deeper treatment – wet face, apply on to damp skin. Leave on for 1 minute. Rinse off thoroughly with warm water. Gently pat dry.

Other information

  • keep tightly closed
  • store in a cool, dry place

Inactive ingredients

water, bentonite, kaolin, glycerin, titanium dioxide, sodium laureth sulfate, niacinamide, sodium lactate, xanthan gum, coco-glucoside, cocamidopropyl betaine, hexyldecanol, sodium hydroxide, fragrance, dipotassium glycyrrhizate, disodium EDTA, bisabolol, cetylhydroxyproline palmitamide, stearic acid, Brassica campestris sterols, FD&C blue no. 1, FD&C yellow no. 6

Questions?

call 1-866-25-CLEAR (1-866-252-5327).

You may also report side effects to this phone number

Distributed by:
Reckitt Benckiser
Parsippany, NJ 07054-0224
Made in USA

PRINCIPAL DISPLAY PANEL - 200 mL Tube Label

Clearasil ®

ULTRA

Acne + Marks
Wash and Mask
Salicylic Acid 2% Acne Medication

REDUCES
MARKS

Helps to clear
pimples fast
and reduce the
appearance of
acne marks

6.78 FL OZ (200 mL)

Principal Display Panel - 200 mL Tube Label
CLEARASIL ULTRA  ACNE PLUS MARKS WASH AND MASK
salicylic acid lotion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:63824-390
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID2 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
BENTONITE (UNII: A3N5ZCN45C)  
KAOLIN (UNII: 24H4NWX5CO)  
GLYCERIN (UNII: PDC6A3C0OX)  
TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
SODIUM LAURETH-3 SULFATE (UNII: BPV390UAP0)  
NIACINAMIDE (UNII: 25X51I8RD4)  
SODIUM LACTATE (UNII: TU7HW0W0QT)  
XANTHAN GUM (UNII: TTV12P4NEE)  
COCAMIDOPROPYL BETAINE (UNII: 5OCF3O11KX)  
HEXYLDECANOL (UNII: 151Z7P1317)  
SODIUM HYDROXIDE (UNII: 55X04QC32I)  
GLYCYRRHIZINATE DIPOTASSIUM (UNII: CA2Y0FE3FX)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
LEVOMENOL (UNII: 24WE03BX2T)  
CETYLHYDROXYPROLINE PALMITAMIDE (UNII: 74ONU0S62G)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
RAPESEED STEROL (UNII: B46B6DD20U)  
FD&C BLUE NO. 1 (UNII: H3R47K3TBD)  
FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:63824-390-88200 mL in 1 TUBE; Type 0: Not a Combination Product09/15/201109/01/2020
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph finalpart333D09/15/201109/01/2020
Labeler - RB Health (US) LLC (081049410)

Revised: 5/2023
Document Id: fc8b3d1d-e16a-d377-e053-6394a90af48d
Set id: 04795bc0-86f2-411a-bb99-c7a9bb28e8af
Version: 3
Effective Time: 20230525
 
RB Health (US) LLC